ZA9710130B - Attenuated live neospora vaccine - Google Patents

Attenuated live neospora vaccine

Info

Publication number
ZA9710130B
ZA9710130B ZA9710130A ZA9710130A ZA9710130B ZA 9710130 B ZA9710130 B ZA 9710130B ZA 9710130 A ZA9710130 A ZA 9710130A ZA 9710130 A ZA9710130 A ZA 9710130A ZA 9710130 B ZA9710130 B ZA 9710130B
Authority
ZA
South Africa
Prior art keywords
attenuated live
live neospora
neospora vaccine
vaccine
attenuated
Prior art date
Application number
ZA9710130A
Other languages
English (en)
Inventor
David A Brake
Byron L Blagburn
David S Lindsay
Original Assignee
Pfizer
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9710130(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer, Univ Auburn filed Critical Pfizer
Publication of ZA9710130B publication Critical patent/ZA9710130B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9710130A 1996-11-12 1997-11-11 Attenuated live neospora vaccine ZA9710130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12

Publications (1)

Publication Number Publication Date
ZA9710130B true ZA9710130B (en) 1999-06-10

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710130A ZA9710130B (en) 1996-11-12 1997-11-11 Attenuated live neospora vaccine

Country Status (16)

Country Link
US (3) US6656479B2 (pt)
EP (1) EP0841392B1 (pt)
JP (2) JP3690709B2 (pt)
CN (2) CN1572322A (pt)
AR (2) AR010583A1 (pt)
AT (1) ATE271122T1 (pt)
AU (1) AU733076B2 (pt)
BR (1) BR9705473A (pt)
CA (1) CA2220588C (pt)
DE (1) DE69729839T2 (pt)
DK (1) DK0841392T3 (pt)
ES (1) ES2224210T3 (pt)
NZ (1) NZ329095A (pt)
PT (1) PT841392E (pt)
TW (1) TW557214B (pt)
ZA (1) ZA9710130B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0841392T3 (da) * 1996-11-12 2004-11-22 Pfizer Svækket levende Neospora vaccine
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
BR9812976A (pt) 1997-10-20 2000-08-08 Bayer Ag Vacina de neospora
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
WO2003038434A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
WO2005007840A1 (en) 2003-07-22 2005-01-27 Vivalis Production of poxviruses with adherent or non adherent avian cell lines
KR20060123346A (ko) * 2003-12-19 2006-12-01 시애틀 바이오메디칼 리서치 인스티튜트 유전적으로 감독된 말라리아 생 백신
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
AU2007283564B2 (en) * 2006-08-09 2013-07-25 Valneva Method of production of transgenic avian using embryonic stem cells
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
CA3003343C (en) 2015-10-28 2024-05-28 Universidad Complutense De Madrid Neospora vaccine composition
CN109789097B (zh) 2016-10-05 2021-05-18 硕腾服务有限责任公司 提供用作强效活疫苗的稳定脱水的原生动物的冻干方法
JP2021525517A (ja) 2018-05-30 2021-09-27 インスティテュート・フォー・リサーチ・イン・バイオメディシンＩｎｓｔｉｔｕｔｅ Ｆｏｒ Ｒｅｓｅａｒｃｈ Ｉｎ Ｂｉｏｍｅｄｉｃｉｎｅ 内在性活性化誘導シチジンデアミナーゼを利用することによるｂリンパ球のエンジニアリング
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
DK0841392T3 (da) * 1996-11-12 2004-11-22 Pfizer Svækket levende Neospora vaccine
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
US6656479B2 (en) 2003-12-02
CA2220588A1 (en) 1998-05-12
DK0841392T3 (da) 2004-11-22
CA2220588C (en) 2008-07-22
MX9708701A (es) 1998-09-30
TW557214B (en) 2003-10-11
BR9705473A (pt) 1999-04-06
US6994861B2 (en) 2006-02-07
JPH10167983A (ja) 1998-06-23
CN1572322A (zh) 2005-02-02
EP0841392A3 (en) 1999-03-24
AU4520397A (en) 1998-05-14
JP3935180B2 (ja) 2007-06-20
AR053286A2 (es) 2007-04-25
PT841392E (pt) 2004-11-30
EP0841392B1 (en) 2004-07-14
CN1190127A (zh) 1998-08-12
DE69729839D1 (de) 2004-08-19
DE69729839T2 (de) 2005-07-21
CN1226406C (zh) 2005-11-09
NZ329095A (en) 1998-03-25
AR010583A1 (es) 2000-06-28
EP0841392A2 (en) 1998-05-13
US20040062772A1 (en) 2004-04-01
ES2224210T3 (es) 2005-03-01
US20060073157A1 (en) 2006-04-06
ATE271122T1 (de) 2004-07-15
US20020044952A1 (en) 2002-04-18
AU733076B2 (en) 2001-05-03
JP2005230018A (ja) 2005-09-02
JP3690709B2 (ja) 2005-08-31

Similar Documents

Publication Publication Date Title
GB9711964D0 (en) Live attenuated vaccines
ZA9710130B (en) Attenuated live neospora vaccine
GB9620795D0 (en) Vaccines
EP0958373A4 (en) Vaccines.
PL331424A1 (en) Antipaludian vaccine composition
ZA979984B (en) Vaccine composition
ZA9711565B (en) Vaccine
GB9625968D0 (en) Vaccine
GB2312047B (en) Improved pipework
GB2316998B (en) Condensate traps
ZA957482B (en) Vaccine
GB9616593D0 (en) Attenuated vaccines
ZA973824B (en) Vaccines
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9419969D0 (en) Vaccine
GB9627145D0 (en) Teat
GB9614182D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9608106D0 (en) Animal Vaccines